Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha

Breast Cancer Research and Treatment

Volumn 118, Issue 2, 2009, Pages 269-279

  Weitsman, Gregory E ^a   Weebadda, Wineeta ^a   Ung, Kanyarat ^a   Murphy, Leigh C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Estrogen receptor; Growth factor receptor; Phosphorylation; Reactive oxygen species

Indexed keywords

1 (2 BUTYL 3 BENZOFURANYL) 1 [5 [2 (DIETHYLAMINO)ETHOXY] 2 THIENYL]METHANONE; 2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; GLUCOSE OXIDASE; GROWTH FACTOR RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN PS2; REACTIVE OXYGEN METABOLITE; SERINE; SMALL INTERFERING RNA; WORTMANNIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HORMONAL THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SERINE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 70350220644     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0221-0     Document Type: Article

References (53)

1. C Osborne R Schiff 2005 Estrogen-receptor biology: continuing progress and therapeutic implications J Clin Oncol 23 1616 1622 10.1200/JCO.2005.10.036 10.1200/JCO.2005.10.036 1:CAS:528:DC%2BD2MXjtVCqur0%3D 15755967 (Pubitemid 46211414)
2. R Dickson G Stancel 2000 Estrogen receptor-mediated processes in normal and cancer cells J Natl Cancer Inst Monogr 27 135 145 1:CAS:528: DC%2BD3cXlvVSnur8%3D 10963625
3. MJ Tsai BW O'Malley 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily Annu Rev Biochem 63 451 486 10.1146/annurev.bi.63.070194.002315 10.1146/annurev.bi.63.070194.002315 1:CAS:528:DyaK2cXkslequr8%3D 7979245
4. D Lannigan 2003 Estrogen receptor phosphorylation Steroids 68 1 1 9 10.1016/S0039-128X(02)00110-1 10.1016/S0039-128X(02)00110-1 1:CAS:528: DC%2BD38XptlGjt7o%3D 12475718 (Pubitemid 35418300)
5. S Ali D Metzger JM Bornert P Chambon 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region EMBO J 12 3 1153 1160 1:CAS:528:DyaK3sXhvVeku78%3D 8458328
6. K Park V Krishnan B O'Malley Y Yamamoto R Gaynor 2005 Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation Mol Cell 18 1 71 82 10.1016/j.molcel.2005.03. 006 10.1016/j.molcel.2005.03.006 1:CAS:528:DC%2BD2MXjt1Oit7k%3D 15808510 (Pubitemid 40444649)
7. S Medunjanin A Hermani BD Servi J Grisouard G Rincke D Mayer 2005 Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity J Biol Chem 280 33006 33014 10.1074/jbc.M506758200 10.1074/jbc.M506758200 1:CAS:528: DC%2BD2MXhtVWiurvM 16076840 (Pubitemid 41368350)
8. G Weitsman L Li G Skliris J Davie K Ung L Curtis-Snell L Tomes P Watson L Murphy 2006 Estrogen receptor-alpha phosphorylated at Serine 118 is present at the promoters of estrogen-regulated genes and is not altered due to Her2 over-expression Cancer Res 66 10162 10170 10.1158/0008-5472.CAN-05-4111 10.1158/0008-5472.CAN-05-4111 1:CAS:528:DC%2BD28XhtVyiur%2FK 17047081 (Pubitemid 44672071)
9. P Joel J Smith T Sturgill T Fisher J Blenis DA Lannigan 1998 pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167 Mol Cell Biol 18 4 1978 1984 1:CAS:528:DyaK1cXitFeqtrY%3D 9528769
10. J Gee J Robertson E Gutteridge I Ellis S Pinder M Rubini R Nicholson 2005 Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer Endocr Relat Cancer 12 Suppl 1 S99 S111 10.1677/erc.1.01005 10.1677/erc.1.01005 1:CAS:528:DC%2BD2MXhtFyitb3N 16113104 (Pubitemid 41395417)
11. M Dowsett S Johnston L Martin J Salter M Hills S Detre M Gutierrez SK Mohsin J Shou D Allred, et al. 2005 Growth factor signalling and response to endocrine therapy: the royal Marsden experience Endocr Relat Cancer 12 Suppl 1 S113 S117 10.1677/erc.1.01044 10.1677/erc.1.01044 1:CAS:528:DC%2BD2MXhtFyitb3P 16113087 (Pubitemid 41395418)
12. P Joel A Traish D Lannigan 1998 Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase J Biol Chem 273 21 13317 13323 10.1074/jbc.273.21.13317 10.1074/jbc.273.21.13317 1:CAS:528:DyaK1cXjsVGgtr4%3D 9582378 (Pubitemid 28246906)
13. R Campbell P Bhat-Nakshatri N Patel D Constantinidou S Ali N Harikrishna 2001 HN: phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance J Biol Chem 276 13 9817 9824 10.1074/jbc.M010840200 10.1074/jbc.M010840200 1:CAS:528: DC%2BD3MXis1Olu7k%3D 11139588
14. M Sun J Paciga R Feldman Z Yuan D Coppola Y Lu S Shelley S Nicosia J Cheng 2001 Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K Cancer Res 61 16 5985 5991 1:CAS:528:DC%2BD3MXmt12ktr0%3D 11507039
15. M Martin T Franke G Stoica P Chambon B Katzenellenbogen B Stoica 2000 A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I Endocrinology 141 4503 4511 10.1210/en.141.12.4503 10.1210/en.141.12.4503 1:CAS:528:DC%2BD3cXosVSqsLw%3D 11108261 (Pubitemid 32055127)
16. J Blenis 1993 Signal transduction via the MAP kinases: proceed at your own RSK Proc Natl Acad Sci USA 90 5889 5892 10.1073/pnas.90.13.5889 10.1073/pnas.90.13.5889 1:CAS:528:DyaK3sXltFWnsL8%3D 8392180
17. A Coutts L Murphy 1998 Elevated mitogen activated protein kinase activity in estrogen non-responsive human breast cancer cells Cancer Res 58 4071 4074 1:CAS:528:DyaK1cXmtlCksrs%3D 9751612
18. C Valley R Metivier N Solodin A Fowler M Mashek L Hill E Alarid 2005 Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus Mol Cell Biol 25 13 5417 5428 10.1128/MCB.25.13.5417-5428.2005 10.1128/MCB.25.13.5417-5428.2005 1:CAS:528:DC%2BD2MXlslCjsbs%3D 15964799 (Pubitemid 40861697)
19. M Callige I Kieffer H Richard-Foy 2005 CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor alpha by the proteasome Mol Cell Biol 25 11 4349 4358 10.1128/MCB.25.11.4349-4358.2005 10.1128/MCB.25.11. 4349-4358.2005 1:CAS:528:DC%2BD2MXkslemsbY%3D 15899841 (Pubitemid 40705742)
20. L Murphy G Weitsman G Skliris E Teh L LI B Peng J Davie K Ung Y Niu S Troup, et al. 2006 Potential role of estrogen receptor alpha phosphorylation at serine 118 in human breast cancer in vivo J Steroid Biochem Mol Biol 102 139 146 10.1016/j.jsbmb.2006.09.021 10.1016/j.jsbmb.2006.09.021 1:CAS:528: DC%2BD28Xht1Cmt7bJ 17092701 (Pubitemid 44750645)
21. H Kamata H Hirata 1999 Redox regulation of cellular signalling Cell Signal 11 1 14 10.1016/S0898-6568(98)00037-0 10.1016/S0898-6568(98)00037-0 1:CAS:528:DyaK1MXhvF2m 10206339 (Pubitemid 28546635)
22. V Skulachev 2000 Mitochondria in the programmed death phenomena; a principle of biology: it is better to die than to be wrong IUBMB Life 49 365 373 10.1080/152165400410209 10.1080/152165400410209 1:CAS:528:DC%2BD3cXks12hsbc%3D 10902567
23. R Burdon 1995 Superoxide and hydrogen peroxide in relation to mammalian cell proliferation Free Radic Biol Med 1 775 794 10.1016/0891-5849(94)00198-S 10.1016/0891-5849(94)00198-S
24. M Sundaresan Z Yu V Ferrans K Irani T Finkel 1995 Requirement for generation of H202 for platelet-derived growth factor signal transduction Science 270 296 299 10.1126/science.270.5234.296 10.1126/science.270.5234.296 1:CAS:528:DyaK2MXoslehs7c%3D 7569979
25. Y Bae S Kang M Seo I Baines E Tekle P Chock S Rhee 1997 Epidermal growth factor (EGF)-induced generation of hydrogen peroxide Biol Chem 272 217 221 10.1074/jbc.272.1.217 10.1074/jbc.272.1.217 1:CAS:528:DyaK2sXjsVKmtA%3D%3D (Pubitemid 27021147)
26. S Gamou N Shimizu 1995 Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor FEBS Lett 357 161 164 10.1016/0014-5793(94)01335-X 10.1016/0014-5793(94)01335-X 1:CAS:528:DyaK2MXjtVSmtLk%3D 7805884
27. A Knebel H Rahmsdorf A Ullrich P Herrlich 1996 Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents EMBO J 15 5314 5325 1:CAS:528:DyaK28XmsVeiu7s%3D 8895576
28. GD Deyulia Jr J Carcama 2005 EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases Biochem Biophys Res Commun 334 38 42 10.1016/j.bbrc.2005.06.056 10.1016/j.bbrc.2005.06.056 1:CAS:528:DC%2BD2MXmt1aqsLo%3D 15982634 (Pubitemid 40978504)
29. J Kwon S Lee K Yang Y Ahn Y Kim E Stadtman S Rhee 2004 Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors Proc Natl Acad Sci USA 101 16419 16424 10.1073/pnas.0407396101 10.1073/pnas.0407396101 1:CAS:528:DC%2BD2cXhtVOisbrN 15534200 (Pubitemid 39557728)
30. K Guyton Y Liu M Gorospe Q Xu N Holbrook 1996 Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury J Biol Chem 271 4138 4142 10.1074/jbc.271.7.3604 10.1074/jbc.271.7.3604 1:CAS:528:DyaK28XhtlSmsb8%3D 8626753 (Pubitemid 26065673)
31. J Abe M Takahashi M Ishida J Lee B Berk 1997 c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 J Biol Chem 272 20389 20394 10.1074/jbc.272.33.20389 10.1074/jbc.272.33.20389 1:CAS:528:DyaK2sXlsFKgtrg%3D 9252345 (Pubitemid 27355589)
32. H Konishi T Fujiyoshi Y Fukui H Matsuzaki T Yamamoto Y Ono M Andjelkovic B Hemmings U Kikkawa 1999 Activation of protein kinase B induced by H(2)O(2) and heat shock through distinct mechanisms dependent and independent of phosphatidylinositol 3-kinase J Biochem 126 1136 1143 1:CAS:528: DC%2BD3cXmt1aksg%3D%3D 10578066
33. A Fritah C Saucier J Mester G Redeuilh M Sabbah 2005 p21WAF/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha Mol Cell Biol 25 2419 2430 10.1128/MCB.25.6.2419-2430.2005 10.1128/MCB.25.6.2419- 2430.2005 1:CAS:528:DC%2BD2MXisVOiurk%3D 15743834 (Pubitemid 40354635)
34. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 402 408 10.1006/meth.2001.1262 10.1006/meth.2001.1262 1:CAS:528: DC%2BD38XhtFelt7s%3D 11846609 (Pubitemid 34164012)
35. V Likhite F Stossi K Kim B Katzenellenbogen J Katzenellenbogen 2006 Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity Mol Endocrinol 20 3120 3132 10.1210/me.2006-0068 10.1210/me.2006-0068 1:CAS:528:DC%2BD28XhtlWks77N 16945990 (Pubitemid 44833560)
36. D Hecht Y Zick 1992 Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro Biochem Biophys Res Commun 188 773 779 10.1016/0006-291X(92)91123-8 10.1016/0006-291X(92)91123-8 1:CAS:528:DyaK3sXitFah 1445322
37. D Barford A Das M Egloff 1998 The structure and mechanism of protein phosphatases: insights into catalysis and regulation Annu Rev Biophys Biomol Struct 27 133 164 10.1146/annurev.biophys.27.1.133 10.1146/annurev.biophys.27.1. 133 1:CAS:528:DyaK1cXktVSltL4%3D 9646865 (Pubitemid 28286012)
38. M Favata K Horiuchi E Manos A Daulerio D Stradley W Feeser DV Dyk W Pitts R Earl F Hobbs, et al. 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase J Biol Chem 273 18623 18632 10.1074/jbc.273.29.18623 10.1074/jbc.273.29.18623 1:CAS:528:DyaK1cXkvVCgur4%3D 9660836 (Pubitemid 28334795)
39. X Liang B Lu G Scott C Chang M Baldwin C Benz 1998 Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancer Mol Cell Endocrinol 146 151 161 10.1016/S0303-7207(98)00161-0 10.1016/S0303-7207(98) 00161-0 1:CAS:528:DyaK1cXntlyksrw%3D 10022773 (Pubitemid 29003290)
40. K Webster H Prentice N Bishopric 2001 Oxidation of zinc finger transcription factors: physiological consequences Antioxid Redox Signal 3 535 548 10.1089/15230860152542916 10.1089/15230860152542916 1:CAS:528: DC%2BD3MXmtlCrtr4%3D 11554443
41. R Whittal C Benz G Scott J Semyonov A Burlingame M Baldwin 2000 Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding Biochemistry 39 8406 8417 10.1021/bi000282f 10.1021/bi000282f 1:CAS:528:DC%2BD3cXkt1Gktbs%3D 10913246 (Pubitemid 30489937)
42. J Quong S Eppenberger-Castori D Moore G Scott K Birrer W Kueng U Eppenberger C Benz 2002 Age-dependent changes in breast cancer hormone receptors and oxidant stress markers Breast Cancer Res Treat 76 221 236 10.1023/A:1020886801674 10.1023/A:1020886801674 1:CAS:528:DC%2BD38Xot12rsLc%3D 12462383 (Pubitemid 35335212)
43. A Oh L Lorant J Holloway D Miller F Kern D El-Ashry 2001 Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells Mol Endocrinol 15 8 1344 1359 10.1210/me.15.8.1344 10.1210/me.15.8.1344 1:CAS:528: DC%2BD3MXlslSgsbs%3D 11463858 (Pubitemid 32703482)
44. A Kronblad I Hedenfalk E Nilsson S Pahlman G Landberg 2005 ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells Oncogene 24 6835 6841 10.1038/sj.onc.1208830 10.1038/sj.onc.1208830 1:CAS:528:DC%2BD2MXhtV2kt7jF 16007158 (Pubitemid 41487042)
45. S Kato H Endoh Y Masuhiro T Kitamoto S Uchiyama H Sasaki S Masushige Y Gotoh E Nishida H Kawashima, et al. 1995 Activation of the estrogen receptor through phosphorylation by mitogen activated protein kinase Science 270 1491 1494 10.1126/science.270.5241.1491 10.1126/science.270.5241.1491 1:CAS:528:DyaK2MXps12hs7o%3D 7491495
46. C Osborne J Shou S Massarweh R Schiff 2005 Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer Clin Cancer Res 11 2 Pt 2 865s 870s 1:CAS:528:DC%2BD2MXislWgu7k%3D 15701879 (Pubitemid 40111098)
47. A Stoica M Saceda V Doraiswamy C Coleman M Martin 2000 Regulation of estrogen receptor-alpha gene expression by epidermal growth factor J Endocrinol 165 371 378 10.1677/joe.0.1650371 10.1677/joe.0.1650371 1:CAS:528: DC%2BD3cXjvFegt7s%3D 10810301 (Pubitemid 30341086)
48. J Shou S Massarweh C Osborne A Wakeling S Ali H Weiss R Schiff 2004 Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer J Natl Cancer Inst 96 12 926 935 1:CAS:528:DC%2BD2cXltVWmtLY%3D 15199112
49. G Arpino S Green D Allred D Lew S Martino C Osborne, et al. 2004 Al. e: HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study Clin Cancer Res 10 5670 5676 10.1158/1078-0432.CCR-04-0110 10.1158/1078-0432. CCR-04-0110 1:CAS:528:DC%2BD2cXntlOqtbY%3D 15355892 (Pubitemid 39180941)
50. S Tamir S Izrael J Vaya 2002 The effect of oxidative stress on ERalpha and ERbeta expression J Steroid Biochem Mol Biol 81 327 332 10.1016/S0960- 0760(02)00115-2 10.1016/S0960-0760(02)00115-2 1:CAS:528:DC%2BD38XnsVWrsLs%3D 12361722 (Pubitemid 35279117)
51. C Cooper G Liu Y Niu S Santos L Murphy P Watson 2004 Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma Clin Cancer Res 10 8720 8727 10.1158/1078-0432.CCR-04- 1235 10.1158/1078-0432.CCR-04-1235 1:CAS:528:DC%2BD2cXhtFGjsLzN 15623657 (Pubitemid 40053441)
52. T Kuukasjarvi J Kononen H Helin K Holli J Isola 1996 Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy J Clin Oncol 14 9 2584 2589 1:CAS:528:DyaK28XlvVGisL0%3D 8823339
53. S Johnston G Saccani-Jotti I Smith J Salter J Newby M Coppen S Ebbs M Dowsett 1995 Changes in estrogen receptor, progesterone receptor and pS2 expression in tamoxifen resistant human breast cancer Cancer Res 55 3331 3338 1:CAS:528:DyaK2MXnt1ansb4%3D 7614468